169 related articles for article (PubMed ID: 35814434)
1. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of
Ondroušková E; Bohúnová M; Závacká K; Čech P; Šmuhařová P; Boudný M; Oršulová M; Panovská A; Radová L; Doubek M; Plevová K; Jarošová M
Front Oncol; 2022; 12():859618. PubMed ID: 35814434
[TBL] [Abstract][Full Text] [Related]
2. Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations.
Blanco G; Puiggros A; Baliakas P; Athanasiadou A; García-Malo M; Collado R; Xochelli A; Rodríguez-Rivera M; Ortega M; Calasanz MJ; Luño E; Vargas M; Grau J; Martínez-Laperche C; Valiente A; Cervera J; Anagnostopoulos A; Gimeno E; Abella E; Stalika E; Hernández-Rivas JM; Ortuño FJ; Robles D; Ferrer A; Ivars D; González M; Bosch F; Abrisqueta P; Stamatopoulos K; Espinet B
Oncotarget; 2016 Dec; 7(49):80916-80924. PubMed ID: 27821812
[TBL] [Abstract][Full Text] [Related]
3. Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.
Amarillo I; Bui PH; Kantarci S; Rao N; Shackley BS; García R; Tirado CA
Mol Cytogenet; 2013 Feb; 6(1):5. PubMed ID: 23369149
[TBL] [Abstract][Full Text] [Related]
4. [Chromosomal aberrations detection in chronic lymphocytic leukemia by conventional cytogenetics using DSP30 and IL-2].
Liu HF; Huang HW; Bai SX; Gong YL; Wu CX; Jin ZM; Wang YY; Yang Q; Zhang J; Qiu HY; Chen SN; Pan JL
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):143-148. PubMed ID: 32135632
[No Abstract] [Full Text] [Related]
5. Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: A single center experience over 12 years.
Kruzova L; Schneiderova P; Holzerova M; Vatolikova M; Divoka M; Turcsanyi P; Urbanova R; Kudelka M; Radvansky M; Kriegova E; Papajik T; Urbankova H
Leuk Res; 2019 Oct; 85():106218. PubMed ID: 31476701
[TBL] [Abstract][Full Text] [Related]
6. Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of
Puiggros A; Collado R; Calasanz MJ; Ortega M; Ruiz-Xivillé N; Rivas-Delgado A; Luño E; González T; Navarro B; García-Malo M; Valiente A; Hernández JÁ; Ardanaz MT; Piñan MÁ; Blanco ML; Hernández-Sánchez M; Batlle-López A; Salgado R; Salido M; Ferrer A; Abrisqueta P; Gimeno E; Abella E; Ferrá C; Terol MJ; Ortuño F; Costa D; Moreno C; Carbonell F; Bosch F; Delgado J; Espinet B
Oncotarget; 2017 Aug; 8(33):54297-54303. PubMed ID: 28903342
[TBL] [Abstract][Full Text] [Related]
7. BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients.
Alhourani E; Othman MA; Melo JB; Carreira IM; Grygalewicz B; Vujić D; Zecević Z; Joksić G; Glaser A; Pohle B; Schlie C; Hauke S; Liehr T
Oncol Lett; 2016 May; 11(5):3240-3246. PubMed ID: 27123097
[TBL] [Abstract][Full Text] [Related]
8. Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
Le Bris Y; Struski S; Guièze R; Rouvellat C; Prade N; Troussard X; Tournilhac O; Béné MC; Delabesse E; Ysebaert L
Hematol Oncol; 2017 Dec; 35(4):664-670. PubMed ID: 27678008
[TBL] [Abstract][Full Text] [Related]
9. Genetic features of B-cell chronic lymphocytic leukemia.
Stilgenbauer S; Lichter P; Döhner H
Rev Clin Exp Hematol; 2000 Mar; 4(1):48-72. PubMed ID: 11486330
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Baliakas P; Jeromin S; Iskas M; Puiggros A; Plevova K; Nguyen-Khac F; Davis Z; Rigolin GM; Visentin A; Xochelli A; Delgado J; Baran-Marszak F; Stalika E; Abrisqueta P; Durechova K; Papaioannou G; Eclache V; Dimou M; Iliakis T; Collado R; Doubek M; Calasanz MJ; Ruiz-Xiville N; Moreno C; Jarosova M; Leeksma AC; Panayiotidis P; Podgornik H; Cymbalista F; Anagnostopoulos A; Trentin L; Stavroyianni N; Davi F; Ghia P; Kater AP; Cuneo A; Pospisilova S; Espinet B; Athanasiadou A; Oscier D; Haferlach C; Stamatopoulos K;
Blood; 2019 Mar; 133(11):1205-1216. PubMed ID: 30602617
[TBL] [Abstract][Full Text] [Related]
11. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG
Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement].
Liu W; Lyu R; Huang WY; Li CW; Liu H; Li J; Zou DH; Qiu LG; Yi SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):761-765. PubMed ID: 28641631
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
[TBL] [Abstract][Full Text] [Related]
14. "Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.
Chapiro E; Lesty C; Gabillaud C; Durot E; Bouzy S; Armand M; Le Garff-Tavernier M; Bougacha N; Struski S; Bidet A; Laharanne E; Barin C; Veronese L; Prié N; Eclache V; Gaillard B; Michaux L; Lefebvre C; Gaillard JB; Terré C; Penther D; Bastard C; Nadal N; Fert-Ferrer S; Auger N; Godon C; Sutton L; Tournilhac O; Susin SA; Nguyen-Khac F;
Am J Hematol; 2018 Mar; 93(3):375-382. PubMed ID: 29194741
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
16. An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.
Rigolin GM; Formigaro L; Cavallari M; Quaglia FM; Lista E; Urso A; Guardalben E; Martinelli S; Saccenti E; Bassi C; Lupini L; Bardi MA; Volta E; Tammiso E; Melandri A; Negrini M; Cavazzini F; Cuneo A
Oncotarget; 2017 Apr; 8(17):28008-28020. PubMed ID: 28427204
[TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia-associated chromosomal abnormalities and miRNA deregulation.
Kiefer Y; Schulte C; Tiemann M; Bullerdiek J
Appl Clin Genet; 2012; 5():21-8. PubMed ID: 23776377
[TBL] [Abstract][Full Text] [Related]
18. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.
Döhner H; Stilgenbauer S; Döhner K; Bentz M; Lichter P
J Mol Med (Berl); 1999 Feb; 77(2):266-81. PubMed ID: 10023780
[TBL] [Abstract][Full Text] [Related]
19. Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia.
Costa D; Granada I; Espinet B; Collado R; Ruiz-Xivillé N; Puiggros A; Uribe M; Arias A; Gómez C; Delgado J; Pereira A; Magnano L; Colomer D; López C; Beà S
Genes Chromosomes Cancer; 2022 Jan; 61(1):37-43. PubMed ID: 34414624
[TBL] [Abstract][Full Text] [Related]
20. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia.
Glassman AB; Hayes KJ
Cancer Genet Cytogenet; 2005 Apr; 158(1):88-91. PubMed ID: 15771912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
